五家金斯顿初创企业获得了超过28万美元的联邦资助，用于开发健康技术，包括治疗尿失禁、青光眼、癌症和慢性疼痛的设备。 Five Kingston startups got over $280K in federal grants to develop health tech, including devices for incontinence, glaucoma, cancer, and chronic pain.

设在金斯敦的五个生命科学新开办企业通过Helix供资方案获得了超过280 000美元的联邦资金,该方案提供10 000至100 000美元的匹配赠款,以支持创新和商业化。 Five Kingston-based life sciences startups have received over $280,000 in federal funding through the Helix Funding program, which provides matching grants of $10,000 to $100,000 to support innovation and commercialization. 受资助的公司正在开发技术,包括压力失禁装置、移植护理数字平台、青光眼智能隐形眼镜、多种癌症液体活性检查工具和慢性疼痛可磨损的工具。 The funded companies are developing technologies including a device for stress incontinence, a digital platform for transplant care, a smart contact lens for glaucoma, a multi-cancer liquid biopsy tool, and a wearable for chronic pain. 该方案由KEDCO管理,并得到验证网络的支持,提供获取专门知识、设备和监管支持的机会。 The program, administered by KEDCO and backed by the Validation Network, offers access to expertise, equipment, and regulatory support. 3月份将开放一个补贴的湿实验室共同工作空间,以解决区域实验室设施短缺的问题,已经对等待名单产生了极大兴趣。 A subsidized wet lab co-working space is set to open in March to address a regional shortage of lab facilities, already drawing significant interest with a waiting list.